IMPACT post hoc analysis identified higher COPD exacerbation rates in winter versus summer. Exacerbation risk was significantly reduced with FF/UMEC/VI versus dual therapy regardless of season, highlighting the durability of response with triple therapy. https://bit.ly/47KAhmK.
No takes yet. Share an insight, caveat, or question.
Criner et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: